da-7867 and garenoxacin

da-7867 has been researched along with garenoxacin* in 1 studies

Other Studies

1 other study(ies) available for da-7867 and garenoxacin

Article	Year
In vitro susceptibility of Mycobacterium tuberculosis clinical isolates to garenoxacin and DA-7867. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:10 The in vitro activities of DA-7867, a novel oxazolidinone, and garenoxacin (BMS-284756) were compared to those of linezolid in 67 susceptible and drug-resistant clinical isolates of Mycobacterium tuberculosis. DA-7867 was the most active drug with an MIC(90) of 0.125 microg/ml, compared to the MIC(90)s of 4 microg/ml of garenoxacin and 2 microg/ml of linezolid. Topics: Acetamides; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones	2005

Article

Year

In vitro susceptibility of Mycobacterium tuberculosis clinical isolates to garenoxacin and DA-7867.

Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:10

The in vitro activities of DA-7867, a novel oxazolidinone, and garenoxacin (BMS-284756) were compared to those of linezolid in 67 susceptible and drug-resistant clinical isolates of Mycobacterium tuberculosis. DA-7867 was the most active drug with an MIC(90) of 0.125 microg/ml, compared to the MIC(90)s of 4 microg/ml of garenoxacin and 2 microg/ml of linezolid.

Topics: Acetamides; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones

2005